SG10201606271RA - Non-aqueous liquid composition - Google Patents
Non-aqueous liquid compositionInfo
- Publication number
- SG10201606271RA SG10201606271RA SG10201606271RA SG10201606271RA SG10201606271RA SG 10201606271R A SG10201606271R A SG 10201606271RA SG 10201606271R A SG10201606271R A SG 10201606271RA SG 10201606271R A SG10201606271R A SG 10201606271RA SG 10201606271R A SG10201606271R A SG 10201606271RA
- Authority
- SG
- Singapore
- Prior art keywords
- liquid composition
- aqueous liquid
- aqueous
- composition
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012018062 | 2012-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201606271RA true SG10201606271RA (en) | 2016-09-29 |
Family
ID=48905235
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404230QA SG11201404230QA (en) | 2012-01-31 | 2013-01-30 | Non-aqueous liquid composition |
| SG10201606271RA SG10201606271RA (en) | 2012-01-31 | 2013-01-30 | Non-aqueous liquid composition |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201404230QA SG11201404230QA (en) | 2012-01-31 | 2013-01-30 | Non-aqueous liquid composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150011518A1 (en) |
| EP (1) | EP2810657B1 (en) |
| JP (1) | JP2013177372A (en) |
| KR (1) | KR20150000874A (en) |
| CN (1) | CN104080478A (en) |
| CA (1) | CA2861261A1 (en) |
| EA (1) | EA201491453A1 (en) |
| IN (1) | IN2014DN06911A (en) |
| PH (1) | PH12014501689A1 (en) |
| SG (2) | SG11201404230QA (en) |
| TW (1) | TW201336526A (en) |
| WO (1) | WO2013115201A1 (en) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
| JP2001524958A (en) * | 1997-04-17 | 2001-12-04 | ジーエス ディベロップメント アクティエボラーグ | A novel liquid crystal based bioadhesive drug delivery system |
| US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| JP4496406B2 (en) | 2003-03-07 | 2010-07-07 | 参天製薬株式会社 | Novel compound having 4-pyridylalkylthio group as a substituent |
| CN1897918A (en) * | 2003-11-17 | 2007-01-17 | 阿尔萨公司 | Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle |
| JP4626353B2 (en) | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | Novel cyclic compound having a 4-pyridylalkylthio group having a substituted or unsubstituted amino group introduced |
| GB0412530D0 (en) * | 2004-06-04 | 2004-07-07 | Camurus Ab | Formulation |
| NZ551990A (en) | 2004-06-04 | 2011-01-28 | Camurus Ab | Liquid depot formulations |
| CA2594710C (en) * | 2005-01-14 | 2011-01-25 | Camurus Ab | Topical bioadhesive formulations |
| PL1843746T3 (en) * | 2005-01-14 | 2011-09-30 | Camurus Ab | Somatostatin analogue formulations |
| JP5127466B2 (en) * | 2005-01-21 | 2013-01-23 | カムルス エービー | Pharmaceutical lipid composition |
| JP4585978B2 (en) | 2005-03-03 | 2010-11-24 | 参天製薬株式会社 | Novel cyclic compounds having a quinolylalkylthio group |
| JP4834441B2 (en) | 2005-03-31 | 2011-12-14 | 参天製薬株式会社 | Novel cyclic compounds having pyrimidinylalkylthio groups |
| CN101217940B (en) | 2005-06-06 | 2013-03-27 | 卡穆鲁斯公司 | Glp-1 analogue formulations |
| JP4825636B2 (en) | 2005-09-14 | 2011-11-30 | 参天製薬株式会社 | Novel 1,2-dihydroquinoline derivatives having glucocorticoid receptor binding activity |
| JP5054996B2 (en) | 2006-03-14 | 2012-10-24 | 参天製薬株式会社 | Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| ES2391910T3 (en) | 2006-11-14 | 2012-12-03 | Santen Pharmaceutical Co., Ltd | 1,2-Dihydroquinoline derivative having a group (substituted phenyl or substituted heterocyclyl) carbonyloxy-lower alkyl and a phenyl group introduced by ester as substituents |
| US8063034B2 (en) | 2007-01-29 | 2011-11-22 | Santen Pharmaceutical Co., Ltd. | Oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity |
| MX2009012885A (en) | 2007-05-29 | 2009-12-10 | Santen Pharmaceutical Co Ltd | Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity. |
| WO2009035068A1 (en) | 2007-09-13 | 2009-03-19 | Santen Pharmaceutical Co., Ltd. | Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| NZ597495A (en) | 2009-07-17 | 2013-08-30 | Santen Pharmaceutical Co Ltd | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof |
| US8956600B2 (en) * | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
-
2013
- 2013-01-30 EP EP13744346.1A patent/EP2810657B1/en not_active Not-in-force
- 2013-01-30 SG SG11201404230QA patent/SG11201404230QA/en unknown
- 2013-01-30 EA EA201491453A patent/EA201491453A1/en unknown
- 2013-01-30 IN IN6911DEN2014 patent/IN2014DN06911A/en unknown
- 2013-01-30 TW TW102103410A patent/TW201336526A/en unknown
- 2013-01-30 JP JP2013015164A patent/JP2013177372A/en active Pending
- 2013-01-30 US US14/375,251 patent/US20150011518A1/en not_active Abandoned
- 2013-01-30 CA CA 2861261 patent/CA2861261A1/en not_active Abandoned
- 2013-01-30 SG SG10201606271RA patent/SG10201606271RA/en unknown
- 2013-01-30 KR KR20147023427A patent/KR20150000874A/en not_active Application Discontinuation
- 2013-01-30 WO PCT/JP2013/051951 patent/WO2013115201A1/en active Application Filing
- 2013-01-30 CN CN201380007257.3A patent/CN104080478A/en active Pending
-
2014
- 2014-07-25 PH PH12014501689A patent/PH12014501689A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201491453A1 (en) | 2014-12-30 |
| US20150011518A1 (en) | 2015-01-08 |
| EP2810657A4 (en) | 2015-07-29 |
| PH12014501689A1 (en) | 2014-10-20 |
| CN104080478A (en) | 2014-10-01 |
| IN2014DN06911A (en) | 2015-05-15 |
| SG11201404230QA (en) | 2014-10-30 |
| KR20150000874A (en) | 2015-01-05 |
| JP2013177372A (en) | 2013-09-09 |
| CA2861261A1 (en) | 2013-08-08 |
| TW201336526A (en) | 2013-09-16 |
| EP2810657B1 (en) | 2016-09-21 |
| WO2013115201A1 (en) | 2013-08-08 |
| EP2810657A1 (en) | 2014-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208372A1 (en) | Liquid formulation | |
| EP2725084A4 (en) | Liquid crystal composition | |
| EP2860236A4 (en) | Liquid-crystal composition | |
| GB201217441D0 (en) | Composition | |
| GB201200707D0 (en) | Composition | |
| EP2927301A4 (en) | Liquid crystal composition | |
| EP2811005A4 (en) | Liquid crystal composition | |
| GB201218954D0 (en) | Composition | |
| PT2935471T (en) | Curable liquid compositions | |
| EP2832814A4 (en) | Liquid coolant composition | |
| EP2878295A4 (en) | Composition | |
| ZA201502036B (en) | Liquid insecticidal composition | |
| ZA201500321B (en) | Liquid detergent composition | |
| GB201219657D0 (en) | Composition | |
| EP2837670A4 (en) | Fluorobiphenyl-containing composition | |
| GB201206035D0 (en) | Composition | |
| EP2910558A4 (en) | Ionic liquid | |
| EP2910537A4 (en) | Gas-generating-agent composition | |
| EP2910538A4 (en) | Gas-generating-agent composition | |
| EP2806012A4 (en) | Liquid crystal composition | |
| EP2772141A4 (en) | Liquid sweetener composition | |
| GB201208133D0 (en) | Composition | |
| GB201219383D0 (en) | Composition | |
| GB201218195D0 (en) | Composition | |
| GB201209597D0 (en) | Composition |